MedPath

Prevalence of BRCA in Patients With Ovarian Cancer

Completed
Conditions
Ovarian Cancer
BRCA Status
Registration Number
NCT02222883
Lead Sponsor
AGO Research GmbH
Brief Summary

The aim of this prospective registration and translational research study is to evaluate the praevalence of BRCA regarding germline and somatic mutations.

Detailed Description

Explorative analysis will be performed.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
530
Inclusion Criteria
  • Female ovarian cancer patients aged >= 18 years.
  • Women with first diagnosis of epithelial ovarian cancer OR women diagnosed with platinum-sensitive recurrent ovarian cancer.
  • Multiple platinum based prior therapies are allowed.
Exclusion Criteria
  • Non-epithelial ovarian malignancy.
  • Platinum-resistant or refractory disease.
  • Paraffin embedded tumor samples not available.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Germline alterations in BRCA1/2 (yes/no) and other ovarian cancer predisposing genes (yes/no; if yes which)once per sample
Secondary Outcome Measures
NameTimeMethod
Results of Immunohistochemistry in tumor samplesonce per sample
Patient Survey for perspectives and satisfaction regarding testing and counselingonce after BRCA result is available

3 questions

Determining the correlation of genetic alterations, cancer treatments, overall survival, progression-free survival and occurrence of new malignanciesonce
Somatic alterations in BRCA1/2 (yes/no) and other ovarian cancer predisposing genes (yes/no; if yes which)once per sample
BRCAness tumor phenotype in ovarian cancer (yes/no).once per sample
Differences of tumor samples from primary and relapsed diseaseonce per sample for each stage of disease

Trial Locations

Locations (19)

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

Universitätsklinik Carl Gustav Carus

🇩🇪

Dresden, Germany

Evangelisches Krankenhaus

🇩🇪

Düsseldorf, Germany

Kliniken Essen-Mitte

🇩🇪

Essen, Germany

Universitätsklinikum Essen

🇩🇪

Essen, Germany

Universitätsklinikum Frankfurt

🇩🇪

Frankfurt/Main, Germany

Universitätsklinikum Hamburg-Eppendorf

🇩🇪

Hamburg, Germany

Medizinische Hochschule Hannover

🇩🇪

Hannover, Germany

NCT Heidelberg

🇩🇪

Heidelberg, Germany

Universitätsklinikum Schleswig-Holstein

🇩🇪

Lübeck, Germany

Scroll for more (9 remaining)
Charité - Universitätsmedizin Berlin
🇩🇪Berlin, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.